Systolic Blood Pressure as a Potential Target of Sigma-1 Receptor Agonist Therapy

Journal of Clinical Hypertension- United States

doi 10.1111/jch.13197

Full Text

Abstract

Available in

Categories

Internal Medicine

Cardiovascular Medicine

Date

January 15, 2018

Authors

Jordana B. Cohen

Michael L. Perlis

Raymond R. Townsend

Publisher

Wiley

Related search

Cardioprotective Effect of the Selective Sigma-1 Receptor Agonist, SA4503

Yakugaku Zasshi

Pharmaceutical Science

English

Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target

Trends in Endocrinology and Metabolism

English

Sigma-2 Receptor as Potential Indicator of Stem Cell Differentiation

Molecular Imaging and Biology

Cancer Research

Nuclear Medicine

English

Clinical Usefulness of the Second Peak of Radial Systolic Blood Pressure for Estimation of Aortic Systolic Blood Pressure

Journal of Human Hypertension

Internal Medicine

English

Sigma 1 Receptor Modulators as a New Weapon Against Multiple Sclerosis

English

Blood Pressure as a Drug Target: What Should We Be Measuring?

British Journal of Clinical Pharmacology

English

A Potent Peptide as Adiponectin Receptor 1 Agonist to Against Fibrosis

Journal of Enzyme Inhibition and Medicinal Chemistry

English

Sp572mean of Pre- And Post-Dialysis Systolic Blood Pressure Is an Independent Predictor of Home Systolic Blood Pressure in Hemodialysis Patients

Nephrology Dialysis Transplantation

Transplantation

English

HIV-1 Capsid as a Target for Antiviral Therapy

Journal of AIDS & Clinical Research

English